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Published byAbstract: This article challenges the idea that cancer cannot be prevented among older adults by
examining different aspects of the relationship between age and cancer. Although the sequential
patterns of aging cannot be changed, several age-related factors that contribute to disease risk can be.
For most adults, age is coincidentally associated with preventable chronic conditions, avoidable
exposures, and modiﬁable risk behaviors that are causally associated with cancer. Midlife is a period
of life when the prevalence of multiple cancer risk factors is high and incidence rates begin to
increase for many types of cancer. However, current evidence suggests that for most adults, cancer
does not have to be an inevitable consequence of growing older. Interventions that support healthy
environments, help people manage chronic conditions, and promote healthy behaviors may help
people make a healthier transition from midlife to older age and reduce the likelihood of developing
cancer. Because the number of adults reaching older ages is increasing rapidly, the number of new
cancer cases will also increase if current incidence rates remain unchanged. Thus, the need to
translate the available research into practice to promote cancer prevention, especially for adults at
midlife, has never been greater.
(Am J Prev Med 2014;46(3S1):S7–S15) Published by Elsevier Inc. on behalf of American Journal of Preventive
Medicine Open access under CC BY-NC-ND license.Grow old along with me! The best is yet to be, the last
of life, for which the ﬁrst was made.
Robert Browning
IntroductionAge, deﬁned by completed units of time,
1 is used
in virtually all studies of cancer epidemiology
and is one of the most studied risk factors for
cancer. Cancer can be considered an age-related disease
because the incidence of most cancers increases with
age,2 rising more rapidly beginning in midlife. Age also
can be considered a surrogate measure for the complex
biological processes associated with aging. However,
aging, the process of getting older, can be distinguished
from age-associated diseases.3 Paradoxically, adults with
the longest longevity are less likely to develop cancer.4–6
Thus, aging can be viewed as a natural process, not
pathology, and old age does not necessarily lead to
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aging also may be involved in the pathogenesis of age-
related diseases such as cancer.3,7 If the environmental
factors that inﬂuence these biologic mechanisms8 can be
modiﬁed, the rate of aging may be slowed and the onset
of cancer delayed or even prevented. The preventability
of many cancers over a person’s life span is supported by
a substantial body of scientiﬁc research.9 This article
reviews the literature on different aspects of the associ-
ation between age and cancer as well as potential
opportunities during midlife to reduce the likelihood of
developing cancer at older ages. It focuses on people aged
45–64 years, while recognizing that this age range is an
arbitrary and imprecise measure of midlife. As described
by Ory and colleagues elsewhere in this supplement,
midlife represents a “watershed” period for cancer
prevention.10Cancer Occurrence at Older Ages
Life expectancy and the percentage of the U.S. population
that is surviving at older ages has increased dramatically
over the last century.11 In 1900, the average life expect-
ancy from birth was 47 years; in 2011, life expectancy
from birth was about 76 years for men and 81 years for
women.12 Just since 1960, life expectancy at age 65 years
has increased by 5 years.13 Life expectancy also shiftse Medicine Am J Prev Med 2014;46(3S1):S7–S15 S7
Table 1. Life expectancy at selected ages, by gender,
U.S., 2011
Life expectancy (years)
Age (years) Male Female
0 76.3 81.1
45 34.0 37.8
50 29.6 33.2
55 25.5 28.8
60 21.5 24.5
65 17.8 20.4
70 14.3 16.5
75 11.0 12.9
80 8.2 9.7
85 5.9 6.9
90 4.1 4.8
95 2.9 3.3
100 2.1 2.3
Note: The life expectancy at a given age for 2011 represents the
average number of years of life remaining if people at that age were to
experience the death rates for 2011 over the course of their
remaining life.
Table 2. Lifetime risk (%) of receiving a diagnosis or dying of
cancer, by age, U.S.
Current
age
(years)
Risk of receiving a cancer
diagnosis
Risk of
dying of
cancer
Z10
years
Z20
years
Z30
years Ever
0 0.17 0.35 0.79 41.24 21.00
10 0.18 0.63 1.67 41.62 21.25
20 0.45 1.5 4.13 41.65 21.31
30 1.06 3.73 9.85 41.74 21.45
40 2.72 8.98 20.14 41.55 21.57
50 6.57 18.29 31.00 40.77 21.55
60 13.09 27.28 35.94 38.20 20.86
70 17.85 28.74 — 31.59 18.56
80 16.83 — — 21.23 14.15
Note: Risk of receiving a cancer diagnosis in 10, 20, or 30 years and
lifetime risk if cancer-free at current age; invasive cancer only; for both
genders and all U.S. racial and ethnic groups combined. Data source
is 18 SEER (Surveillance, Epidemiology, and End Results) Areas,
2007–2009.
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example, in 2011, men aged 65 years were expected to
live another 18 years (total life expectancy of 83 years),
whereas women aged 65 years were expected to live
another 20 years (total life expectancy of 85 years). More
than half of the adults aged 85 years in 2011 can expect to
live at least another 6 years. During 2010–2050, the
number of adults aged 85 years and older in the U.S. is
projected to grow from 5.5 million to 19 million.13
The risk of receiving a diagnosis of different types of
cancer varies throughout a person’s life span. The
cumulative risk for all cancers combined increases with
age, up to age 70 years then decreases slightly (Table 2).14
For the total U.S. population, the lifetime risk of ever
being diagnosed with cancer is approximately 41%.14
However, a substantial proportion of older adults will
reach the end of their life span without clinically detected
cancer (excluding indolent tumors). After age 90 years,
cancer is uncommon as a cause of disease or death.6
Still, slightly more than half of all cancers in 2009
occurred in adults agedZ65 years (Figure 1).2 Over time,
the shape of this curve is expected to shift toward a
greater number of cancer cases at older ages as the Baby
Boom generation born after World War II ages. In
addition, the total number of cancers is projected to
increase by 45% from 2010 to 2030,15 driven largely bythe growing number of older adults. By 2030, an
estimated 70% of all cancers will occur among adults
aged Z65 years. The challenges posed to the U.S.
healthcare system by the expected increase in cancer
incidence are considerable10,11,16,17 and point to the
growing need to focus on opportunities for primary
prevention rather than relying on treatment alone.Midlife as a Critical Period in the Life
Course for Cancer Risk and Prevention
Cancer development is a complex process that occurs
over a span of many years.18 A life course approach10,19,20
is particularly well suited to understanding the contribu-
tions of various cancer risk factors over a person’s life
span. As Rando observed, the biologic processes of aging
are mysterious and highly variable.8 Aging is inﬂuenced
by genetically determined processes but also can be
modiﬁed by environmental inﬂuences.8,15,21 For exam-
ple, cigarette smoke is thought to accelerate the aging
process.22
When applied to cancer research, the life course
approach has been used to examine the inﬂuence of
prenatal and early life events on cancer development in
adulthood.23,24 A recent federal, interagency report on
breast cancer research, for example, highlighted evidence
that exposures that cause molecular and cellular changes
in mammary tissue during puberty or earlier canwww.ajpmonline.org
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Figure 1. Invasive cancer incidence, by age, U.S., 2009
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The ﬁnding that breast cancer incidence rates fell after
the decline in the use of hormone replacement therapy at
menopause suggests that critical periods for breast cancer
development also exist later in life.26 In addition,
opportunities may exist to intervene at midlife to alter
or reverse disease processes that were initiated at earlier
life stages.27
As a marker of time, age captures the duration of
exposures and the accumulation of cancer risk.28 Nine
hallmarks of aging have been proposed,29 including
genomic instability and epigenetic alteration, which are
also the hallmarks of cancer.18 Whether the relationship
between age and cancer risk is due primarily to the time-
dependent accumulation of genetic and epigenetic muta-
tions or to an increased susceptibility of older adults to
oncogenic mutations is not fully understood.30,31 The
multifactorial process of transformation from normal
cells to cancer includes the accumulation of DNA
damage and mutations over time coupled with disrup-
tions of the DNA repair and cell growth regulation
system.18,32
The role of epigenetic alterations such as DNA
methylation in the complex aging process is an emerging
area of research.33 Although the potential for reversing
gene expression suggests a role for dietary or other
modiﬁcations, the biological or clinical signiﬁcance of
these epigenetic changes have yet to be fully elucidated.34
Risk factors such as environmental or occupational
exposures to chemical and physical agents, tobacco
smoke, and viral infections might affect different points
along this multistep process of transformation and
accelerate damage; removing these risk factors may
reverse damage.35 Current research also suggests that
the transformation to malignancy requires age-associated
changes in the cellular microenvironment or tissue, such
as increased inﬂammation or decreased immune func-
tion that selects for mutations that support proliferation
and dissemination of transformed cells.36,37 PrecursorMarch 2014lesions, such as the adenomatous polyp in colorectal
cancer, may be prevented from progressing to cancer
through risk factor modiﬁcation and intervention.38 It
has also been proposed that calorie restriction or drugs
that possess anti-aging activity may be able to delay or
prevent cancer.39 Thus, midlife and older age can be seen
as a time of increased vulnerability to cancer and an
appropriate focus for expanded research and prevention
efforts.
Radiation exposure in particular has been associated
with increasing cancer risks for people at midlife. For
most adults, their greatest exposure to ionizing radiation
is from medical imaging.40 Use of medical imaging
procedures such as CT scans and PET scans has
increased dramatically over the past 20 years, particularly
among those in midlife who have chronic conditions.41,42
Evidence from epidemiologic studies and models of
radiation-induced cancer show that exposures to radia-
tion during midlife may increase risk more than expo-
sures at other ages.43 This evidence is consistent with
research showing that the processes that promote cancer
may also increase at older ages.43 Vulnerability to cancer
has also been demonstrated for exposure to ultraviolet
radiation during midlife. A recent meta-analysis of
sunburns and melanoma concluded that sunburn at
any age increases the risk of cutaneous melanoma,44
suggesting the importance of preventing excessive sun
exposure not only among the young but across the
life span.
Increased Prevalence of Selected Chronic
Conditions and Infections with Age
Health at midlife establishes the foundation for health
and longevity later in life. Midlife is also the time when
some well-recognized risk factors for cancer and other
diseases (e.g., tobacco use, lack of physical activity, poor
nutrition, excessive alcohol consumption, certain
chronic infections) begin to demonstrate an impact.45,46
The prevalence of several preventable chronic conditions
and diseases, such as obesity and diabetes, tends to
increase during midlife, and some of these conditions
have been associated with increased cancer risk and
reduced cancer survival. Although members of the current
generation of adults aged 45–64 years are expected to live
longer than members of earlier generations, they are also
experiencing higher rates of chronic conditions such as
obesity and diabetes, and they tend to rate their health
lower than previous generations at the same age.27,47 Thus,
the prevention or management of chronic conditions and
the promotion of general health during midlife are
promising strategies to prevent or delay cancer incidence
at older ages.
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Type 2 diabetes is associated with an increased risk of
developing cancer of the colon; breast (post-meno-
pausal); and pancreas.48–50 Approximately 11.7% of
U.S. adults aged 45–64 years have received a diagnosis
of diabetes, and prevalence is even higher (18.9%) among
those agedZ65 years.51 According to blood glucose data
from the National Health and Nutrition Examination
Survey, many more U.S. adults may have undiagnosed
diabetes.52 Diabetes accelerates biologic aging and is
recognized as a rapidly growing problem among older
adults.53 Thus, efforts to prevent and better manage
diabetes during midlife could reduce the risk for certain
cancers later in life.Weight and Metabolic Syndrome
Excess body weight has also been linked to an increased
risk of many types of cancer, including cancer of the
esophagus; pancreas; thyroid; gallbladder; colon and
rectum; breast (post-menopausal); endometrium; and
kidney.50,54–56 Visceral adipose tissue produces cytokines
that create chronic inﬂammation and promote tumor
growth through multiple biologic mechanisms.57,58
According to data collected in 2009–2010, the prevalence
of obesity was 35.7% among U.S. adults agedZ20 years
and 36.6% among adults aged 40–59 years.59
Excess body weight contributes to metabolic syn-
drome,58 which has also been linked to increased cancer
risk.53,60,61 The National Cholesterol Education Pro-
gram’s Adult Treatment Panel III report deﬁnes meta-
bolic syndrome as the presence of three or more of the
following characteristics: abdominal obesity (waist cir-
cumference4102 cm for men and488 cm for women);
triglycerides Z150 mg/dL; low high-density lipoprotein
(HDL) cholesterol (o40 mg/dL for men ando50 mg/dL
for women); blood pressure ofZ135/Z85 mmHg; and a
fasting glucose Z100 mg/dL.62 During 2003–2006, the
percentage of adults meeting the criteria for metabolic
syndrome was more than twice as high among those aged
40–59 years (41% of men and 37% of women) than
among those aged 20–39 years (20% of men and 16% of
women).63 Facilitating healthy dietary choices and phys-
ical activity among adults may potentially help to not
only reduce the prevalence of metabolic syndrome but
also reduce risk for certain related cancers.Infections
Chronic infection with hepatitis C virus (HCV) is
associated with an increased risk of hepatocellular
carcinoma and other HCV-related liver disease.64 The
prevalence of HCV infection in the U.S. is highest among
adults who were born during 1945–1965 (3.25%) becauseof the substantial number of incident infections during
the 1970s and 1980s and the persistence of chronic HCV
infection.64 New antiviral treatments are available that
can halt HCV-related disease progression and provide a
cure for HCV infection in most people.64,65 The CDC
recommends one-time testing for HCV among adults
born during 1945–1965 as a strategy for reducing HCV-
related morbidity and mortality.64 The U.S. Preventive
Services Task Force (USPSTF) recently updated its
review of the evidence on HCV screening and now also
recommends offering one-time screening to adults born
between 1945 and 1965.66,67 If a person is found to be
infected with HCV, preventive care can be offered to
limit the progression from HCV infection to liver cancer.
A substantial proportion of older adults are sexually
active,68 and thus at risk of sexually transmitted infec-
tions. Infections of special concern are HIV and human
papillomavirus (HPV). HIV infection is associated with
an increased risk of several non-AIDS cancers (e.g., anal
cancer, Hodgkin’s disease, liver cancer), perhaps because
of HIV-associated immune dysfunction.3 Oncogenic
HPV is associated with cervical, vulvar, vaginal, penile,
anal, and oropharyngeal cancers, and incidence rates for
these cancers increase after age 50 years.69 Older adults
are at special risk because they are less likely to use a
condom, and their health professionals may fail to ask
about unsafe sexual behaviors.70 Even at midlife, safe
sexual practices can reduce the risk of cancers associated
with HPV or HIV infection.
The Social Dimension of Age
Causal paradigms for cancer typically categorize age
along with gender, race, and ethnicity as individual
characteristics that are not amenable to intervention.71
Just as research has shown a lack of precision in various
racial and ethnic categories,72 a great deal of hetero-
geneity can exist within any age category.73 In addition,
the experience of age is subject to social and cultural
inﬂuences. Although the challenges of examining differ-
ences by race and ethnicity without contributing to
societal racism has been noted previously,72,74,75 the
inﬂuence of stereotypes and prejudice based on age has
received far less attention.76,77
Age prejudice has been characterized as “one of the
most socially-condoned and institutionalized forms of
prejudice.”78 Pervasive myths of aging and stereotypes
about age76 need to be recognized and addressed by both
older adults and healthcare providers when addressing
cancer prevention at midlife. When a person believes that
aging leads to poor health, this belief can operate as a self-
fulﬁlling prophecy and contribute to poor health.79,80 A
meta-analysis of research on age stereotypes demonstratedwww.ajpmonline.org
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inﬂuence on adult behavior than did positive age stereo-
types, and that the harmful effect of pervasive negative
stereotypes about age is not easily offset by less-frequent,
positive stereotypes.79 The perception among some
healthcare providers that illnesses such as cancer are an
inevitable part of the aging process may lead to a focus on
disease management instead of prevention.78 If the
detrimental effects of negative age stereotypes can be
avoided, then opportunities for cancer prevention among
older adults are more likely to be recognized and pursued.
Approaches to Cancer Prevention at Midlife
A large body of evidence supports the use of selected
cancer screening technology as one approach to cancer
control in midlife. Currently, the USPSTF has identiﬁed
sufﬁcient evidence to support population screening for
only a few cancers—colorectal, cervical, and female
breast cancer—as a way to reduce cancer deaths.81 In
December 2013, the USPSTF issued a recommendation
on annual lung screening with low-dose CT scans, but
only for people at high risk for lung cancer.82 Some types
of screening tests, such as the Pap test for cervical cancer,
involve the identiﬁcation and subsequent removal of
precancerous lesions before they develop into cancer.
Other types of screening tests, such as mammography for
breast cancer, are limited to the early detection of cancer.
Less attention has focused on approaches for the
primary prevention of cancer at midlife, a point in the
life course when incidence rates for most cancers begin to
increase signiﬁcantly. Given the growing understanding
of the variety of factors that are associated with cancer
risk, more opportunities to make changes to prevent
cancer are becoming evident. Although the sequential
patterns of aging cannot be changed,83 the factors that
contribute to the development of chronic diseases,
including cancer, can be changed to promote a healthier
transition from midlife to older age. Evidence supports,
to varying degrees, an association between increased risk
for cancer and prevalent behaviors among U.S. adults,
such as smoking, excessive alcohol consumption, poor
sleep hygiene, a diet lacking in fruits and vegetables and
high in red meat, and insufﬁcient physical activity.84–86
Smoking
Smoking cessation is an important example of how the
adoption of a healthy behavior in midlife can help
prevent cancer. Smoking reduces life expectancy by
about 10 years but smokers who quit can beneﬁt from
reduced risk.87 One study from the United Kingdom
found that smoking cessation even up to age 60 years
signiﬁcantly reduced the risk of developing lung cancer.87March 2014Similar ﬁndings from two studies in the U.S. showed that
life expectancy was extended and risk of death associated
with continued smoking was signiﬁcantly reduced for
those who quit smoking in midlife.88,89 At any age,
smokers should be encouraged to quit and offered
assistance to achieve success in quitting.
Alcohol
The mechanisms by which excessive alcohol consump-
tion causes cancer, including DNA damage, formation of
DNA adducts, production of reactive oxygen species,
chronic inﬂammation, folate and other nutritional deﬁ-
ciencies, and increased estrogen concentration, are not
well studied and differ by target organ.90,91 However,
adequate evidence exists to support a linear dose–
response relationship between alcohol intake and
increased cancer risk, with no safe level of consump-
tion.54,90 Thus, limiting or avoiding alcohol consumption
may reduce the risk of cancer.92
Other Health-Related Behaviors
Emerging evidence points to the association of sleep
disturbance and cancer risk,93 suggesting that good sleep
hygiene may help prevent cancer in adults. In addition,
increasing physical activity and reducing time spent
engaging in sedentary behaviors (e.g., sitting) may be a
particularly important strategy for cancer prevention at
midlife.10
Behavioral Interventions
Sabia and colleagues94 studied middle-aged adults in the
context of successful aging, ﬁnding that those in midlife
who ate a healthy diet, refrained from smoking and
excessive alcohol use, and engaged in moderate levels of
physical activity were less likely than study participants
who did not engage in healthy behaviors to suffer from
cancer 16 years after the study began. In a subsequent
report based on the same study cohort, diet at midlife was
found to be associated with overall health at older ages.95
In particular, adults who consumed a diet high in fried
foods, sweets, processed food, red meat, reﬁned grains,
and high-fat dairy products were less likely to meet the
criteria for ideal aging at follow-up. Other research has
demonstrated that behavior change in midlife—such as
eating more fruits and vegetables daily, exercising regu-
larly, maintaining a healthy weight, and not smoking—
was associated with a reduced risk of cardiovascular
disease and death.96 However, physical activity and fruit
and vegetable intake decreased among adults during
1988–2006.97 Thus, more research is needed on effective
interventions and policy and environmental strategies to
increase and sustain healthy behaviors in midlife and
older ages.
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Another way to prevent cancer is to reduce people’s
exposures to environmental carcinogens,98 and many
known human carcinogens (e.g., asbestos, benzene,
formaldehyde, radon, and ultraviolet radiation) are
highly prevalent in the general environment, consumer
products, or the workplace.99 In 2012, 75.2% of U.S.
adults aged 45–54 years and 60.6% of those aged 55–64
years were employed,100 making exposure to occupa-
tional carcinogens especially relevant at this stage of life.
The National Institute for Occupational Safety and
Health has identiﬁed more than 130 substances as
potential occupational carcinogens.101 Many thousands
of chemicals and other substances are in use but have
never been evaluated for possible carcinogenicity.98
Workplace hazards, working conditions, and personal
risk factors may interact to contribute to chronic diseases
such as cancer among working adults.102 Primary pre-
vention policies that reduce exposure to known carci-
nogens have been found to reduce cancer risk (e.g.,
eliminating exposure to asbestos to reduce lung can-
cer).103 In addition, for potentially large numbers of
workers, the workplace could be an effective place to use
comprehensive strategies that protect and promote
health for adults at midlife and at older ages.104,105
Conclusion
More than 30 years ago, James Fries proposed a model
for national health that would delay the onset of disease
with age so that more adults could reach the end of life
disease-free.106 As life expectancy has increased and the
number of older Americans has grown, so have efforts to
promote healthy aging.107 However, the occurrence of
cancer at older ages poses unique challenges to achieving
a high quality of life.108 Patients and providers both need
to recognize that for most adults, age is coincidentally
associated with preventable chronic conditions, avoid-
able exposures, and modiﬁable health habits that are
causally associated with cancer. In addition to changing
individual behaviors to reduce cancer risk, multilevel
system and environmental interventions that address
multiple diseases and risk factors could prevent or delay
the occurrence of cancer and other age-related dis-
eases.109,110 Clinical preventive services that address
multiple chronic conditions and health behaviors at
midlife also are important for cancer prevention later
in life. To increase their effectiveness, these clinical
services could be supported and reinforced by
community-based prevention policies and programs.111
The workshop summary in this supplement highlights
potentially promising approaches and strategies for
cancer prevention at midlife.112Current research suggests that for most adults, cancer
does not have to be an inevitable consequence of growing
older. On the contrary, the prevention or at least delay of
cancer occurrence can be viewed as an effective strategy
for achieving a healthy, long life. By applying the
available scientiﬁc evidence to promote cancer preven-
tion at midlife, it should be possible to substantially
modify the relationship between age and cancer risk.Publication of this article was supported by the Division of
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